-+ 0.00%
-+ 0.00%
-+ 0.00%
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
Share
Listen to the news

PDUFA target action date of November 28, 2026, approximately one quarter ahead of Company’s previously communicated guidance

FDA identified no Filing review issues

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending